MEISSA VACCINES INC

Profile

Company Names

MEISSA VACCINES INC

Addresses

329 OYSTER POINT BOULEVARD, 3RD FLOOR, SOUTH SAN FRANCISCO, CA 94080

329 OYSTER POINT BOULEVARD, 3RD FLOOR, SAN FRANCISCO, CA 94080

Phone Numbers

650-356-0494

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$15,157,667.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2019-09-17 
$13,916,583.00 
$33,916,581.00 
$19,999,998.00 
Equity 
1
2016-07-25 
$1,241,084.00 
$5,000,000.00 
$3,758,916.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ISAAC 
 
CHENG 
DIRECTOR
LIQUIDIA TECHNOLOGIES INC   |  BIOSCALE INC   |  EDISON PHARMACEUTICALS INC   |  ATREAON, INC.   |  SYNCHRONEURON INC.   |  AMYLYX PHARMACEUTICALS, INC.   |  TORPEDO DIAGNOSTICS, INC.   |  DNATRIX INC   |  ADJUVANCE TECHNOLOGIES INC.   |  INCARDA THERAPEUTICS, INC.   |  MEISSA VACCINES INC   |  TALLAC THERAPEUTICS, INC.   |  APNIMED, INC.   |  MEDRHYTHMS, INC.
WILLIAM 
 
DALY 
DIRECTOR
AERPIO THERAPEUTICS, INC.   |  BLACKROCK US CORE PROPERTY FUND, L.P.   |  MEISSA VACCINES INC
KENNETH 
 
KELLEY 
DIRECTOR
MEISSA VACCINES INC
MARTIN 
 
MOORE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
REAL ESTATE SUB-FUND OF M+G ASIA PROPERTY FUND   |  MEISSA VACCINES INC
STEPHANIE 
 
O?BRIEN 
DIRECTOR
MEISSA VACCINES INC
RODERICK 
 
TANG 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MEISSA VACCINES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-10-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-17 
2017-10-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-25 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#